Closing of Probiodrug-Prosidion Transaction and Changes in Management & Board

Probiodrug awarded a € 1.9mio BioChancePlus grant to fund a drug-discovery program for the treatment of neurodegenerative disorders
Morphochem and Probiodrug collaborate in research and development of novel innovative dipeptidyl peptidase IV (DP IV) inhibitors for the treatment of Anxiety and Depression